版本:
中国

BRIEF-Radius Health says FDA approves co's TYMLOS

April 28 Radius Health Inc :

* FDA approves Radius Health’s TYMLOS™ (abaloparatide), a bone building agent for the treatment of postmenopausal women with osteoporosis at high risk for fracture

* US commercial launch in May for TYMLOS Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐